Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - GREENE BARRY E
Last Updated 
20-Mar-17
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

GREENE BARRY E: Declared Holdings
Company/RelationshipReportedShares  Ownership
Acorda Therapeutics, Inc.
Director
NasdaqGS:ACOR
(historical quotes, profile, other insiders)
9-Feb-170  Direct
Alnylam Pharmaceuticals, Inc.
Officer
NasdaqGS:ALNY
(historical quotes, profile, other insiders)
1-Dec-1688,584  Direct
Karyopharm Therapeutics Inc.
Director
NasdaqGS:KPTI
(historical quotes, profile, other insiders)
2-Apr-153,000  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
9-Feb-17 723ACOR Option Exercise at $22.13 per share.
(Cost of $15,999)
9-Feb-17 723ACOR Automatic Sale at $22.65 per share.
(Proceeds of $16,375)
3-Jan-17 3,017ACOR Automatic Sale at $19.26 per share.
(Proceeds of $58,107)
3-Jan-17 3,017ACOR Option Exercise at $15.91 per share.
(Cost of $48,000)
1-Dec-16 55,605ALNY Option Exercise at $22.75 per share.
(Cost of $1,265,013)
1-Dec-16 31,825ALNY Automatic Sale at $42.61 - $44.07 per share.
(Proceeds of about $1,379,000)
24-Mar-16 16,540ALNY Option Exercise at $7.10 - $9.14 per share.
18-Nov-15 2,100ALNY Disposition (Non Open Market) at $0 per share.
4-Aug-15 26,972ALNY Option Exercise at $9.14 - $31.39 per share.
26-May-15 67,379ALNY Option Exercise at $13.12 - $13.12 per share.
(Cost of about $884,000)
26-May-15 67,379ALNY Automatic Sale at $125 - $125 per share.
(Proceeds of about $8,422,000)
2-Apr-15 3,000KPTI Purchase at $29.31 - $29.31 per share.
(Cost of about $88,000)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?